A grounded daily brief

August 13, 2026

The signal across world affairs, markets, technology, and health — in a few focused minutes.

26stories
21min read

At a glance

TL;DR

6 signals to orient your day.

  1. 01US and Iran clash over Hormuz control as shipping traffic plungesWorld & Politics
  2. 02S&P 500 Sets Record High as Cooling Inflation and Falling Oil Prices Boost StocksFinance & Markets
  3. 03Autonomous AI agents used in first known fully automated cyberattack on TaiwanTechnology & Innovation
  4. 04Cullinan, Taiho's Zipalertinib-Chemotherapy Combo Meets Key Goal in Phase 3 NSCLC Trial; Stock UpHealth & BioTech
  5. 05China Surpasses US in Drug Trials and Supply Chain, Survey ShowsHealth & BioTech
  6. 06Zelensky says Ukraine recaptured 745 sq km in southeastern sector ‘exactly as planned’World & Politics

World & Politics

World & Politics

04 stories
01
GeopoliticsLow confidence

US and Iran clash over Hormuz control as shipping traffic plunges

On August 13, 2026, Washington and Tehran made opposing claims over the Strait of Hormuz. President Donald Trump said the US has “total control” of the waterway and intends to keep it, while Iran’s military rejected this as “lies” and said the strait remains blocked until its conditions are accepted. Shipping data showed traffic near a three-month low: 13 vessels transited on Tuesday, about 90% below the pre-war daily average, and only 3 ships transited in the past 24 hours per the Hormuz Strait Monitor. Since the war began on February 28, Iran has effectively shut the strait, and the US has imposed a naval blockade. As of August 12, US forces had redirected 59 commercial vessels, disabled 3, and boarded 2. Defense Secretary Hegseth said the US Navy can maintain the blockade indefinitely.

The standoff has major global energy and security implications. Hormuz previously carried about one-fifth of the world’s oil and liquefied natural gas. The IEA forecasts world oil demand will decline by 1.6 million barrels per day in 2026 partly because of the strait’s ongoing closure. Iran has also suggested it could prolong the war until Trump leaves office to deter future US attacks. The dispute complicates stalled negotiations, fuels regional attacks on shipping, contributed to an oil spill off Oman, and has strained US forces, prompting the replacement of the USS Abraham Lincoln after more than 200 days without a port call.

02
EuropeLow confidence

Zelensky says Ukraine recaptured 745 sq km in southeastern sector ‘exactly as planned’

Volodymyr Zelensky said Ukrainian forces have recaptured 745 sq km of territory in the southeastern Oleksandrivka sector since the start of the year, and that the operation, which began in January, went “exactly as planned”. He also confirmed a massive overnight Ukrainian attack on Russia's Novorossiysk naval base using drones, missiles, and unmanned boats.

The claims and continued strikes underline that the war remains active in its fifth year. Zelensky said Ukraine needs 5% of US Patriot interceptor stocks to survive winter and 10% to destroy all Russian ballistic missiles, while currently receiving only 1% of what the US makes.

03
Food Security & GeopoliticsReview carefully

Russia warns of ‘chaos’ in global food market after Ukraine pummels grain terminals

Three of Russia’s largest grain terminals in the Black Sea port of Novorossiysk have halted operations after being damaged in a massive overnight drone attack by Ukraine. Grain shipments from Novorossiysk are currently impossible because of serious damage to terminal infrastructure. Russia said on Wednesday that Ukrainian strikes on its grain and agricultural infrastructure were pushing up global food prices and exacerbating grain shortages.

Russia and Ukraine account for more than a quarter of global wheat exports, and the attacks come in the middle of this year’s harvest. Wheat futures jumped as much as 4 per cent in Chicago on Wednesday for the biggest intraday advance in three weeks, raising concerns about supplies.

04
Diplomacy

Japan Protests Putin's Visit to Etorofu Island

On August 13, Prime Minister Takaichi said she was informed that President Putin visited Etorofu Island and strongly protested, noting that the Northern Territories are Japan's inherent territory and that the visit is incompatible with Japan's position and unacceptable.

The visit hurts Japanese public sentiment, makes it more difficult to restore Japan-Russia relations over the medium to long term, and occurs amid already strained relations due to Russia's aggression against Ukraine.

Finance & Markets

Finance & Markets

08 stories
01
US StocksLow confidence

S&P 500 Sets Record High as Cooling Inflation and Falling Oil Prices Boost Stocks

On August 13, U.S. stocks advanced, with the S&P 500 hitting an intraday record of 7,816.7, led by technology and semiconductor shares. The Nasdaq Composite rose 1.04% and the Dow Jones added 0.34%. July producer prices rose 4.7% from a year earlier, below the 4.9% estimate, while Brent crude fell more than 2% to about $87 amid demand worries and rising inventories. Traders raised the odds of the Fed holding rates steady next month to 65%.

The cooler-than-expected wholesale inflation and falling oil prices ease fears of resurgent price pressures, reducing the likelihood of an imminent Fed rate hike. That supports higher-valuation growth stocks and overall risk appetite. However, policy uncertainties and lack of progress on U.S.-Iran tensions remain a headwind.

02
Foreign ExchangeReview carefully

Goldman says Japan has enough firepower for more yen intervention rounds

Goldman Sachs estimates that Japan holds about $200 billion in cash-equivalent reserves, enough for another couple of yen-buying operations on the scale of the July intervention, which may have totaled $85 billion in its first two days. Access to the Federal Reserve's FIMA repo facility could make nearly all of Japan's $1 trillion dollar reserves available for intervention. The yen has slipped back to near 160 per dollar, giving back about half the gains made after the joint U.S.-Japan intervention in late July, which was the first such action since 1998.

The report suggests Japan has substantial capacity to keep supporting the yen, even though Goldman calls intervention 'not a sustainable fix' that only 'buys some time.' With a 65% market-implied probability of a Bank of Japan rate hike in September, a failure to act could renew downward pressure on the yen and raise intervention odds. The analysis also highlights how the Fed's backstop facility has shifted trader sentiment, as the yen's renewed slide to 160 keeps the market on guard for sudden intervention-driven moves.

03
Monetary PolicyLow confidence

PBOC Signals Diversified Loan Pricing Benchmarks, Greater Focus on Overnight Rates

In its second-quarter monetary policy report released Wednesday, the People's Bank of China said it would promote more diversified loan-pricing benchmarks and further refine its short-term interest rate framework. It reiterated a moderately loose policy stance, pledging 'comprehensive use' of tools and 'timely adjustments' to maintain ample liquidity. The report notably dropped earlier wording about reforming the loan prime rate.

The notable change in the PBOC's report language signals a shift from previous loan prime rate reform messaging toward a more diversified loan-pricing benchmark system. This indicates a potential evolution in China's approach to setting loan rates and refining its short-term interest rate framework.

04
FinanceLow confidence

Bank of Korea Buys $250 Million Gold ETF, First Gold Move in 13 Years

The Bank of Korea reported holding about 355 billion won ($250 million) worth of gold exchange-traded funds in the second quarter, including 679,765 shares of the SPDR Gold Trust valued at $250.41 million as of the end of June. It is the first time the BOK has invested in gold since buying 20 tons of physical gold in 2013. The central bank also said it plans to buy physical gold, though the timing has not been set.

The move signals that the BOK may expand its gold-related assets going forward, and physical gold purchases could resume as early as this year. Because gold ETFs are counted as part of the country's foreign exchange reserves, this adds a new element to reserve management.

05
Monetary Policy

RBA sees monetary policy as somewhat restrictive as housing softens and global forces weigh

At its meeting earlier this week, the RBA’s Monetary Policy Board judged that monetary policy is somewhat restrictive. The three cash rate increases earlier this year are having their intended effects: borrowing costs and mortgage payments have risen, housing credit growth has slowed, Sydney and Melbourne housing prices have declined, and the Australian dollar has appreciated by around 5 per cent on a trade-weighted basis since the start of the year. The assessment is supported by estimates placing the current cash rate around the top of the range of central estimates of the nominal neutral rate. The Board also flagged uncertainty from a housing downturn that seems larger than the recent rate rises alone would explain, and from AI-related investment and large public debts globally that could make financial conditions less restrictive.

This assessment underpins the RBA’s forecasts for slow growth of aggregate demand, which is needed to reduce capacity pressures and bring inflation back to target. Yet other forces can alter how restrictive policy actually is. A softer housing market may make financial conditions more restrictive than the cash rate alone implies, while resilient global demand from AI investment and higher bond yields abroad from large public debts tend to make Australian financial conditions less restrictive, potentially requiring a higher cash rate than otherwise. These crosscurrents will be central to the Board’s future decisions.

06
Central banking & economicsLow confidence

Central banks forecast growth more accurately than inflation, benchmark finds

The Economics Benchmarks 2026 report found 61.3% of 31 central bank economics departments said their growth forecast errors were roughly in line with the historical average in 2025, while 48.4% said the same for inflation errors. For both variables, errors were more likely to come in lower than the historical average than higher.

The findings suggest central banks have been more reliable at projecting real growth than headline inflation, highlighting which economic variable remains harder to forecast for policymakers.

07
Central Banking & Money Markets

CBN Eases Bank Liquidity Rules and Opens OMO Auctions to Individuals and Companies

The Central Bank of Nigeria overhauled its money-market framework, effective immediately. Banks can now use the Standing Lending Facility on the same day they trade in the foreign-exchange market or participate in primary government-securities auctions, though not on a day they bid in an OMO auction. The CBN also resumed tenored repo operations running from 4 to 90 days and widened access to OMO auctions to all eligible investors, including individuals, companies and non-bank financial institutions. Banks will continue to submit bids and settle transactions for these investors.

The changes come three weeks after the MPC held its benchmark rate at 26.5% for a second straight meeting, with inflation at 15.91% in June. The CBN is keeping the main rate tight while making daily liquidity management more flexible, giving banks easier access to funding and a wider investor pool for OMO auctions. Recent OMO auctions cleared at 19.9%–21.9%, so direct access could give individuals and non-bank institutions those yields. The next test is the MPC meeting on September 21-22, 2026, and whether money-market borrowing costs shift even with the benchmark rate unchanged.

08
EconomicsReview carefully

Rising Bond Yields and Elevated Leverage Spur Financial Stability Warnings

US 30-year Treasury yields have risen more than 40 basis points this year to around 5.2 percent, the highest since 2007, while leverage across financial markets continues to build. Customer margin debt reached a record $1.5 trillion in June, up 49 percent year over year, and banks held $325 billion in unrealized securities losses in Q1 2026. AI and semiconductor stocks have lost over $3 trillion in market capitalization this year.

The combination of rising yields, record leverage, and a tech-stock correction could expose vulnerabilities and amplify losses, potentially spilling into broader market crises. With US budget deficits at 6 percent of GDP and debt exceeding the economy, authorities and market participants are urged to take precautionary measures to prevent systemic risks.

Technology & Innovation

Technology & Innovation

08 stories
01
Cybersecurity

Autonomous AI agents used in first known fully automated cyberattack on Taiwan

Over four days in July, autonomous AI agents attacked Taiwan government systems, mapping 21 systems, cracking 85 user accounts and extracting 2,500 personnel records, according to Israeli AI firm Dream. The attack also hit Taiwan's nuclear safety agency and at least seven energy companies. Dream said up to eight open-source AI agents coordinated the intrusion without human intervention. Taiwan officials said the attack originated overseas and involved a hybrid approach with conventional hacking and AI agents. Experts suspect China due to simplified Chinese in internal documents, but no origin was confirmed.

Experts believe this is the first known fully autonomous attack on a government, with AI agents strategizing, learning and adapting on their own. Dream warned that the cost of running a competent attack has collapsed while defense costs have not, raising fears about the proliferation of AI-enabled cyberattacks and prompting calls for stronger government regulation and defensive strategies.

02
Semiconductors

SK hynix to break ground on $3.87B Indiana chip packaging plant this month

SK hynix will hold a groundbreaking ceremony on Aug. 27 for its $3.87 billion advanced chip packaging plant in West Lafayette, Indiana. The facility will focus on high-bandwidth memory (HBM) packaging and is set to begin mass production in the second half of 2028. The U.S. government has committed up to $450 million in direct funding and $500 million in loans under the CHIPS Act. SK Group Chairman Chey Tae-won and SK hynix CEO Kwak Noh-jung are expected to attend; Nvidia CEO Jensen Huang's attendance is not confirmed.

The Indiana plant gives SK hynix a U.S.-based production base for advanced HBM packaging, meeting rising demand for AI-related memory. It also underscores deeper ties with Nvidia and opens the door to further U.S. investment, including a possible memory production facility.

03
EconomicsReview carefully

AI Spending Drives Up Consumer Prices as Inflation Stays Above Target

A new report finds that heavy corporate investment in AI is raising consumer prices, as AI requires enormous computing power and chips, whose costs are passed on to electronics and software. The July Consumer Price Index showed inflation at a 3.4% annual pace, while information technology commodities rose 1.4% from the previous month. Electricity costs also rose 4.2% from a year ago due to data center energy use.

Inflation remains well above the Federal Reserve's 2% target, and rising tech costs are a significant contributor. As consumers compete with businesses for AI-related components, prices for goods like phones and software subscriptions increase. Economists expect this AI-related price boost to continue for the next two years, affecting household budgets and monetary policy.

04
Technology

Naver Invests in Startup Building Wave-Powered AI Data Centers

Naver has invested in Panthalassa, a U.S. startup developing offshore AI data centers powered by wave energy. The investment was made through U.S. venture capital firm 8090 Industries; the amount was not disclosed. Panthalassa's floating 'Node' platform generates electricity from waves, cools servers with seawater, and transmits data via low-Earth-orbit satellites. Having demonstrated Ocean-1 and Ocean-2, the company plans to deploy Ocean-3 this year and targets commercialization in 2027.

As AI data centers face surging electricity demand and land constraints, wave-powered offshore data centers could offer a renewable, cost-efficient alternative—they need no separate power plant or fuel and use seawater for cooling. LEO satellite links also reduce geographic limits for AI inference. This investment reflects Naver's push to secure differentiated AI infrastructure and strengthen its competitiveness in the global AI infrastructure market.

05
TechnologyReview carefully

US startups power AI with biology, ocean waves, and microreactors

AI's energy demands are rising. Biological Computing uses rat brain cells and stem cells to make AI models more efficient, with one upgrade delivering efficiency gains as high as 500%. Panthalassa is building floating data centers powered by wave-driven turbines. Valar Atomics proved its RV-sized microreactor works safely and closed a $1 billion Series B round led by Sequoia Capital to mass-produce the reactors for future data centers.

These next-generation solutions aim to keep AI running strong without draining the planet, addressing the growing energy and environmental challenges of AI.

06
Trade PolicyLow confidence

U.S. Polysilicon Tariffs Split Korean Industry: Semiconductor Burden, Solar Opportunity

The U.S. imposed Section 232 tariffs on polysilicon and derivatives, including a 15% tariff on wafers. Korean firms reacted differently: SK Siltron (semiconductor wafers) fears higher costs and market shrinkage; OCI (polysilicon) expects windfall gains as Chinese products become less competitive; Hanwha Q CELLS sees short-term cost burdens but potential long-term benefits from U.S. local production expansion. The Korean government is gathering industry feedback and seeking clarification from the U.S.

The tariffs could alter global supply chains, impacting Korea's semiconductor and solar exports. U.S. onshoring incentives and tax credits (like 45X AMPC) may prompt Korea to introduce similar support measures. The industry is watching whether such trade measures could extend to other advanced sectors, affecting Korea's industrial competitiveness.

07
Cybersecurity

Researcher creates workaround for Microsoft Defender security patch

A researcher known as Nightmare Eclipse posted a proof-of-concept (PoC) bypass called ShieldBreak that appears to let an attacker with any level of access gain system-level privileges, bypassing Microsoft's fix for CVE-2026-50656. Microsoft said it is investigating the claims. Independent researchers, including Steven Eric Fisher and Will Dormann, have reportedly confirmed the exploit works, though it uses a different Defender/Cloud Filter API path than the original RoguePlanet exploit.

The bypass undermines confidence in official patches because organizations may believe they are protected after deploying the fix, while the exposure can persist. It could serve as a near-ideal second stage for ransomware crews. Experts urge CISOs to assume the exploit is live, adopt defense-in-depth measures like application allowlisting, tighten privileges, and watch for suspicious activity such as an interactive shell running as system with the parent process MsMpEng.exe.

08
AI & Cybersecurity

OpenAI launches GPT-5.6-Cyber, completing 95% of offensive-security tasks

On August 10, OpenAI launched GPT-5.6-Cyber under its expanded Daybreak program. The model completed 95% of tasks on OpenAI's internal Advanced Cybersecurity Completion Rate benchmark, while the safety-locked public version completed only 1.5%. It identified two previously unknown bugs in Chrome's V8 engine that could be chained to escape the sandbox; Google patched them as CVE-2026-15903 in Chrome 150.0.7871.128. OpenAI says the model also surfaced at least five vulnerabilities in a major mobile operating system, three critical bugs in a widely used database, and more than 400 privilege-escalation issues in an OS kernel. Access is limited to vetted security firms and vendors, with hardware security keys mandatory for all Daybreak accounts from September 1, 2026.

The roughly 93-point gap between the Cyber model (95%) and the public model (1.5%) shows what happens when refusal training is stripped out for vetted users. The Chrome exploit is a real-world demonstration of AI finding and chaining memory-corruption bugs, and the restricted Daybreak Red access is a head start for defenders rather than permanent containment. It arrives in a 2026 news cycle that already includes AI-driven social engineering and an AI system finding 14,090 real open-source bugs in two months, signaling that offensive AI tooling is now an active threat.

Health & BioTech

Health & BioTech

06 stories
01
OncologyReview carefully

Cullinan, Taiho's Zipalertinib-Chemotherapy Combo Meets Key Goal in Phase 3 NSCLC Trial; Stock Up

The Phase 3 REZILIENT3 trial, evaluating zipalertinib plus platinum-based chemotherapy in the first-line treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC), met its primary endpoint of progression-free survival (PFS) at an interim analysis. The trial enrolled 285 adults with previously untreated, EGFR exon 20 insertion-mutated non-squamous NSCLC. The study showed a statistically significant and clinically meaningful improvement in PFS in the zipalertinib-containing arm, with manageable safety. The Independent Data Monitoring Committee recommended unblinding the study, and full results will be submitted for presentation at an upcoming international medical conference. Following the news, Cullinan Therapeutics' stock (CGEM) rose 6.33% to $20.84 in after-hours trading, reaching a new 52-week high.

This positive Phase 3 result represents an important milestone for the zipalertinib program, as it may offer a new first-line treatment option for patients with EGFR exon 20 insertion mutations, a population with significant unmet need. The trial's success also boosted investor confidence, as reflected by the stock's rise to a new 52-week high.

02
Biotech

China Surpasses US in Drug Trials and Supply Chain, Survey Shows

A June Cure Innovation Index survey found China ahead of the U.S. in clinical drug development and supply chain, two of six measured domains. Roughly a third of new drugs Big Pharma licensed in now come from Chinese labs, according to Dr. Nathan Goodyear. Merck signed a $2 billion licensing deal in March 2025 for HRS-5346, a cardiovascular drug developed in China. The U.S. launched Operation TrailBlazer in late June and Congress introduced the Biotech Investment National Security Act to screen outbound biotech investment.

The shift affects patient access and national security. Restricting partnerships too abruptly could hurt cancer patients by reducing pipeline candidates, longer timelines, and less price competition, said Dr. Goodyear. A survey of 117 leaders found 76% say the U.S. leads but China is closing fast, 85% say the U.S. lead lasts 10 years or less. The U.S. is responding with policy measures, while some companies like Amgen expand domestic production. The real question, Goodyear says, is resilience, not dependence.

03
Biopharmaceuticals & Drug Development

Celltrion Wins U.S. Fast Track for All Three ADC Candidates

Celltrion said all three of its antibody-drug conjugate (ADC) candidates in clinical development — CT-P70, CT-P71 and CT-P73 — have received Fast Track designation from the U.S. FDA. The designation for CT-P73 covers recurrent or metastatic cervical cancer in patients previously treated with platinum-based chemotherapy. Two of the three candidates will complete Part 1 of their Phase 1 trials within this year and begin releasing topline results in the first half of next year. CT-P70 is aiming to enter Part 2 in March next year. Celltrion also plans to apply to the FDA within this year for Fast Track designation for CT-P72, a multispecific antibody-based candidate.

Fast Track designation can speed development and review for treatments addressing serious conditions with high unmet medical need. It allows more frequent FDA consultation and potential rolling review, though it does not guarantee approval. With all three ADC candidates carrying the designation, Celltrion aims to improve development efficiency and differentiate strategies for each pipeline. The company is also expanding beyond ADCs into multispecific antibodies to build a long-term growth engine following its biosimilar business.

04
Biotechnology & Clinical TrialsReview carefully

Hyundai Bioscience Doses First Patient in Phase 1 Trial for 'Penitrium' Targeting 80-Year-Old Pseudo-Resistance Puzzle

Hyundai Bioscience announced on the 13th that it has administered the first dose in the low-dose group of its Phase 1 clinical trial for 'Penitrium', a new anticancer drug. The trial, led by Professor Chang-wook Jeong of Seoul National University Hospital, is the world's first to directly verify in humans the 'pseudo-resistance' problem. The first patient is a prostate cancer patient whose PSA levels have surged and who no longer responds to conventional hormone therapy. The trial will enroll patients in low-, medium-, and high-dose groups, combining Penitrium with existing hormone therapy for three months to monitor whether efficacy is restored and assess safety.

This trial aims to solve an 80-year-old challenge in oncology: pseudo-resistance, where cancer cells do not acquire resistance but drugs fail to reach lethal doses due to a physical barrier in the tumor microenvironment. Penitrium dismantles this barrier, restoring drug delivery to lethal levels. If validated, it could delay or avoid switching to chemotherapy with side effects and reduce metastasis risk. The company has filed patents in 23 countries and plans to launch a pancreatic cancer trial, proceeding directly to a global Phase 2 study if interim analysis confirms efficacy.

05
Biopharmaceuticals

ArkBio Receives China IND Approval for Influenza Prophylaxis Candidate AK0406

ArkBio announced that China's NMPA approved its IND application for AK0406 injection, a long-acting antiviral drug-Fc conjugate (AFC) for influenza prophylaxis, making it the first influenza AFC drug to enter clinical development in China. A Phase I trial in Australia received HREC approval in February 2026; enrollment and dosing of all healthy adult volunteer cohorts have been completed and the trial is now in follow-up.

Seasonal influenza vaccines face limitations such as antigenic drift, uncertain strain prediction, and reduced efficacy in elderly and immunocompromised populations. AK0406 is designed to provide sustained pre- and post-exposure prophylaxis with broad-spectrum activity against influenza A and B viruses, potentially addressing high unmet needs for influenza prevention. ArkBio is pursuing a parallel dual-track development pathway in China and globally to accelerate delivery of a safer, more effective solution.

06
MicrobiologyReview carefully

Commensal bacteria inhibit viral infections via a tryptophan metabolite

A study published in Nature Communications on 13 August 2026 reports that commensal bacteria inhibit viral infections via a tryptophan metabolite. The authors have filed a patent application covering the therapeutic use of ArAT-expressing bacteria and their metabolites in viral infections. The research received funding from NIH, Gilead Sciences, and other sources.

The findings suggest a novel antimicrobial mechanism and may support the development of new therapeutic strategies for viral infections, as indicated by the patent application.